Progentec
Delaware corporation · 1 known investors
Progentec develops diagnostic and digital health solutions for autoimmune disease detection and treatment, including biomarker tests and remote monitoring technologies for clinicians and patients. The company focuses on improving health outcomes for the 25 million Americans living with autoimmune diseases.
Founders & leadership
MP
Mohan PurushothamanCEO
MP
Mohan Purushothaman, Ph.D.President, Chairman, & CEO
RS
Robert SaundersDirector
SS
Sanjiv SharmaExecutive Officer, Director
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$2.5MraisedNov 2018 · 7 investors · BiotechnologyRule 506(c)
▶$2.5MraisedNov 2018 · 7 investors · Biotechnology
Rule 506(c)Officers, directors & promoters on the filing
- Robert SaundersDirector
- Mohan PurushothamanExecutive Officer, Director
- Sanjiv SharmaExecutive Officer, Director
- Offering amount
- $2.5M
- Amount sold
- $2.5M
- Minimum investment
- $75K
- Proceeds to insiders
- $150K
- First sale
- Nov 2017
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06c
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
- Progentec Secures $5M in Series A Funding - FinSMEsfinsmes.com · 2020
- Progentec Raises $5M in Series A Funding Led by Plains Venture Partnersprnewswire.com · 2020
- Progentec Diagnostics Completes Second Funding Round - FinSMEsfinsmes.com · 2018
- Progentec Diagnostics, Inc. Raises Funds to Support Advances in Lupus Detection and Managementprnewswire.com · 2018